Navigation Links
Kitty Castellini Wins Roche Diabetes Care's Diabetes Heroes' Torchbearer Challenge
Date:12/2/2011

wiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

About Kitty Castellini

Kitty Castellini, Founder, President and CEO of Diabetes Living Today®, has more than 47 years of experience with diabetes. Castellini is recognized as a national thought leader about diabetes by pharmaceutical companies, research institutes and those living with the disease. She is an active advocate for cure-focused research and fundraising. In 2007, the U.S. Congress acknowledged Castellini's impressive work in helping others who suffer from diabetes through her writing, fundraising and interviews. The State of New Jersey Senate honored her for her exemplary service, steadfast commitment and praiseworthy history of inspired leadership on behalf of her fellow citizens.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact:

Todd Siesky 
Public Relations Manager
Roche Diabetes Care
Indianapolis, IN
(317) 521-3966 O
(317) 361-7637 C
todd.siesky@roche.com 

 


'/>"/>
SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Roche Signs Agreement with PTC Therapeutics to Advance Treatment for Spinal Muscular Atrophy (SMA)
2. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
3. Electrochemistry controlled with a plasma electrode
4. Roche Licenses Nanopore Sequencing Technologies from Arizona State University and Columbia University for Rapid, Affordable DNA Sequencing
5. Roche NimbleGen Announces New Pre-capture Multiplexing for Target Enrichment Technology in Sequencing
6. Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
7. Roche Submits Acute Hepatitis B Test to FDA for Premarket Approval
8. China Agri-Business Acquired Management and Operation Rights of Shaanxi Qinfeng Agrochemical Inc. in Xian, China
9. Proceedings of the National Academy of Sciences (PNAS) Publishes Roche Manuscript on Production of Bispecific IgG Antibodies
10. Roche Building Awarded LEED® Gold Certification
11. Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... provider of scientific, technical and medical information products and ... in Reproductive BioMedicine Online on ... abnormal chromosomal composition can be identified by the rate ... the risk of genetic abnormality without a biopsy. In ... retrospective study, using their predictive model to assess the ...
(Date:5/17/2013)... May 17, 2013 New ... most innovative thought leaders of the medical device ... East conference and expo, from June 18-20 in ... (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... deliver industry professionals practical presentations and implementable solutions ...
(Date:5/17/2013)... May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased ... with Switzerland -based Kenta Biotech ... monoclonal antibody (mAb) products, and technologies. This asset ... for treatment of infections by common pathogens including ... , Pseudomonas aeruginosa , Acinetobacter baumannii ...
(Date:5/17/2013)... May 17, 2013 The paradigm of ... biological systems that can help predict the adverse and ... Sergey Stepaniants, Head of Computational Biology at the Genomics ... tools to ensure high-quality genomics when used as part ... applied to complex data sets to identify key clinical ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3
... Milestone Validates Approach, SAN FRANCISCO, January 22 ... its first clinical trial, a,proof-of-concept study that evaluated ... blocker. Rufinamide was discovered and,developed by Novartis and ... a,drug to treat a form of epilepsy. This ...
... B.V. announced today the closure of its Series ... Ventures., Progentix Orthobiology B.V. was established in ... products for clinical application,in bone regenerative surgery. Progentix ... biomaterial scaffolds that have the ability to,attract growth ...
... NorTech Venture,Capital Advisory Task Force reported in its inaugural ... generate and attract over $1.2 billion,in venture capital by ... companies,located in Northeast Ohio. According to the findings from ... region, to be,released in print mid February, Northeast Ohio ...
Cached Biology Technology:Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 2Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders 3Progentix Orthobiology B.V. Closes Series A Financing Round 2Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 2Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 3Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 4Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007 5
(Date:5/16/2013)... (May 17, 2013) Illustrating a commitment to ... American Gastroenterological Association (AGA) Research Foundation has announced ... Research Fellowship Award recipients. Supported by the National ... (NIDDK), this new award helps underrepresented minority students ... and nutrition research. , "By establishing this new ...
(Date:5/16/2013)... (Maximizing Access to Research Careers) Program has announced ... Developmental Biology (SDB) 72nd Annual Meeting in Cancun, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... the stability of today,s largest ice sheets in Greenland and ... ago, for example when Earth was going through a ... high sea level due to ice sheet collapse at that ... if the world,s largest ice sheets collapsed in the past, ... progressively warming world. , However, a new groundbreaking study ...
Breaking Biology News(10 mins):Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2
... Autism Speaks, the nation,s largest autism science and advocacy ... to investigate genetic and environmental risk factors for autism. ... multi-site studies focusing on a collaborative prospective study of ... who are at higher genetic risk for developing the ...
... legs learned to walk upright. So did Faith, ... "half-man" born without legs, grew naturally into a graceful hand-walker. ... Hensel live successfully with separate heads connected to a single ... to drive, swim, shuffle cards and play piano. In ...
... that modern lifestyle habits may play a bigger role than ... A review of the scientific evidence over the past 150 ... hygiene and health education, may override the effects of food ... a Supplement to the journal Obesity Reviews . ...
Cached Biology News:Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 2Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 3Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 4Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 5'Freaks' help scientist unravel nature and nurture 2'Freaks' help scientist unravel nature and nurture 3
Candida (IgG) -Ab EIA Sample Size: 5 l...
... Oxidized LDL (Competitive) EIA Principle: ... the monoclonal antibody 4E6. Oxidized LDL in the ... LDL bound to the microtiter well for the ... a washing st Sample Size: 25 ...
... RNase III, used with its manganese-containing reaction ... heterogeneous mix of short (1825 bp) interfering ... mammalian cells. 1.3 units (1 l) of ... 1 g of dsRNA into siRNA suitable ...
For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site Efficient 6xHis tag cleavage (greater than 90%), ...
Biology Products: